Xbrane Assembles The Troops As FDA Says No To Lucentis Biosimilar

Complete Response Letter Flags Two Issues, Although No More Clinical Trials Required

 
• By Dean Rudge
  
Denied
• Source: Alamy
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products